News
Before the market opened on Wednesday, Thermo Fisher's stock price rose slightly. According to reports, it is close to acquiring clinical trial software company Clario for $10 billion. This move aligns with Thermo Fisher's strategy to expand its capabilities in the field of clinical trial data management. The acquisition deal may be announced soon, but the terms may change
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments